Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates in two segments, MedSurg and Cardiovascular. The company offers devices to diagnose and treat a range of gastrointestinal conditions, such as resolution clips, biliary stent systems, stents and electrocautery enhanced delivery systems, direct visualization systems, digital catheters, and single-use duodenoscopes, as well as endoluminal surgery and infection prevention portfolios; devices to treat urological conditions, including ureteral stents, catheters, baskets, guidewires, urinary and bowel dysfunction, sheaths, balloons, single-use digital flexible ureteroscopes, holmium laser systems, penile implants, artificial urinary sphincter, laser system, and hydrogel systems; and devices to treat neurological movement disorders and manage chronic pain, such as spinal cord stimulator systems, proprietary programming software, radiofrequency ablation, indirect decompression systems, and intraosseous nerve ablation and deep brain stimulation systems. It also provides technologies for diagnosing and treating coronary artery disease and aortic valve conditions; WATCHMAN FLX, a left atrial appendage closure (LAAC) device; and implantable devices that monitor the heart and deliver electricity to treat cardiac abnormalities, such as cardioverter and cardiac resynchronization therapy defibrillators, MRI S-ICD systems, cardiac resynchronization therapy pacemakers, quadripolar LV leads, ICD leads, pacing leads, remote patient management systems, insertable cardiac monitor systems, and remote cardiac monitoring systems. In addition, the company offers diagnosis and treatment of rate and rhythm disorders of the heart; peripheral arterial and venous diseases; and products to diagnose, treat, and ease forms of cancer. The company was incorporated in 1979 and is headquartered in Marlborough, Massachusetts.

Boston Scientific Corporation

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Boston Scientific (BSX – Research Report) and Elevan...

Analysts Offer Insights on Healthcare Companies: Boston Scientific (BSX) and Elevance Health (ELV)

Blackstone Minerals Ltd ( ($AU:BSX) ) has shared an update. Blackstone Minerals Limited has announced that managing director Scott Williamson cease...

Blackstone Minerals Details Scott Williamson’s Exit and Ongoing Equity Interests

U.S. stocks ended the week lower as pressure from rates and commodities weighed on risk appetite. The Dow Jones Industrial Average (DJIA) fell 0.36...

The Week That Was, The Week Ahead: Macro and Markets, Feb. 1

Blackstone Minerals Ltd ( ($AU:BSX) ) has issued an update. Blackstone Minerals reported a mixed December quarter marked by both regulatory headwin...

Blackstone Balances Social Licence Wins and Work Halt at Mankayan as Leadership Shifts and Cash Remains Strong

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Travere Therapeutics (TVTX – Research Report) and Bo...

Analysts Offer Insights on Healthcare Companies: Travere Therapeutics (TVTX) and Boston Scientific (BSX)

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Boston Scientific (BSX – Research Report) and ACADIA...

Analysts Offer Insights on Healthcare Companies: Boston Scientific (BSX) and ACADIA Pharmaceuticals (ACAD)

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on TransMedics Group (TMDX – Research Report), Beam T...

Analysts’ Opinions Are Mixed on These Healthcare Stocks: TransMedics Group (TMDX), Beam Therapeutics (BEAM) and Boston Scientific (BSX)

Boston Scientific ($BSX) announced an update on their ongoing clinical study. Study OverviewBoston Scientific is launching a first‑in‑human study t...

Boston Scientific Advances CHORUS IDx: New Imaging Study Targets Smarter Atrial Ablation

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Henry Schein (HSIC – Research Report) and Boston Sci...

Analysts Are Bullish on These Healthcare Stocks: Henry Schein (HSIC), Boston Scientific (BSX)

Which stocks are best to buy now? According to Top Wall Street Analysts, the three stocks listed below are Strong Buys. Each stock received a new B...

3 ‘Strong Buy’ Stocks to Buy Today,1/16/2026, According to Top Analysts

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Boston Scientific (BSX – Research Report), Atea Pharmaceuticals (...

Analysts Offer Insights on Healthcare Companies: Boston Scientific (BSX), Atea Pharmaceuticals (AVIR) and Penumbra (PEN)

In a report released today, Matt Miksic from Barclays maintained a Buy rating on Boston Scientific, with a price target of $136.00. According to Ti...

Barclays Sticks to Its Buy Rating for Boston Scientific (BSX)

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Disc Medicine (IRON – Research Report) and Boston Sc...

Wall Street Analysts Are Bullish on Top Healthcare Picks

Analysts’ Top Healthcare Picks: Disc Medicine (IRON), Boston Scientific (BSX)

Traders seeking the hottest earnings reports, analysts updates, deals, and more will find them in the TipRanks daily wrap-up.


Morning News Wrap-Up: Thursday’s Biggest Stock Market Stories!

Bernstein analyst Lee Hambright maintained a Buy rating on Boston Scientific today and set a price target of $130.00. Hambright covers the Healthca...

Bernstein Reaffirms Their Buy Rating on Boston Scientific (BSX)

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Prestige Consumer Healthcare (PBH – Research Report)...

Analysts Are Bullish on Top Healthcare Stocks: Prestige Consumer Healthcare (PBH), Boston Scientific (BSX)

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Atricure (ATRC – Research Report) and Boston Scienti...

Analysts Offer Insights on Healthcare Companies: Atricure (ATRC) and Boston Scientific (BSX)

Exchange-traded funds (ETFs) offer investors a broad and often daunting array of options. TipRanks’ AI analysts pare this universe down to three ET...

3 Best ETFs to Invest In, According to AI Analyst, 01/12/2026

RBC Capital analyst Shagun Singh Chadha maintained a Buy rating on Boston Scientific on January 7 and set a price target of $130.00. The company’s ...

Boston Scientific (BSX) Receives a Buy from RBC Capital

Boston Scientific ($BSX) announced an update on their ongoing clinical study. Study OverviewBoston Scientific is running a clinical study titled “A...

Boston Scientific’s AXIOS™ Gastroenterostomy Trial Paused: What Investors Should Watch

Boston Scientific ($BSX) announced an update on their ongoing clinical study. Study Overview The RAINBOW study, officially titled “French Prospecti...

Current Quarter	$0.78	Next Quarter	$0.79
Current Year	$3.04	Next Year	$3.44
QoQ Growth	+1.3%	YoY Growth	+13.2%
3Y EPS CAGR	+22.2%	Target Price	$125.53
Consensus	Buy	Upside	+36.6%

Current Quarter Rev	N/A	Next Quarter Rev	N/A
Revenue Growth	N/A	YoY Growth	N/A

	A	B	C	D
1	Symbol	Price	Change	Volume
2	BSX	$91.87	-1.77%	15.42M
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	BSX	$91.87	-1.8%	15.42M
3
4
5
6

BSX

BSX

EPS Estimates Overview

EPS Historical Trend (5 Years)

Quarterly EPS Estimates

Revenue Analysis

Get Boston Scientific Corporation Data in Excel

Get Boston Scientific Corporation Data in Excel